See more : Workday, Inc. (WDAY) Income Statement Analysis – Financial Results
Complete financial analysis of Merit Medical Systems, Inc. (MMSI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Merit Medical Systems, Inc., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
You may be interested
- K&S Corporation Limited (KSC.AX) Income Statement Analysis – Financial Results
- Aena S.M.E., S.A. (ANYYY) Income Statement Analysis – Financial Results
- Solid State plc (SOLI.L) Income Statement Analysis – Financial Results
- FLEETCOR Technologies, Inc. (0IPN.L) Income Statement Analysis – Financial Results
- Mathew Easow Research Securities Limited (MATHEWE.BO) Income Statement Analysis – Financial Results
Merit Medical Systems, Inc. (MMSI)
About Merit Medical Systems, Inc.
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. The company also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems. In addition, it provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate strictures; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures. The company sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.26B | 1.15B | 1.07B | 963.88M | 994.85M | 882.75M | 727.85M | 603.84M | 542.15M | 509.69M | 449.05M | 394.29M | 359.45M | 296.76M | 257.46M | 227.14M | 207.77M | 190.67M | 166.59M | 151.40M | 135.95M | 116.23M | 104.04M | 91.45M | 78.00M | 68.40M | 60.60M | 50.50M | 42.60M | 33.30M | 25.40M | 18.40M | 10.50M | 4.40M | 1.40M |
| Cost of Revenue | 673.49M | 631.88M | 589.42M | 562.70M | 562.49M | 487.98M | 401.60M | 338.81M | 306.37M | 284.47M | 254.68M | 212.30M | 193.98M | 168.26M | 148.66M | 133.87M | 127.98M | 117.60M | 97.49M | 83.91M | 75.23M | 67.71M | 65.94M | 56.50M | 44.30M | 39.60M | 35.10M | 26.90M | 23.30M | 17.40M | 12.30M | 7.60M | 3.80M | 2.00M | 1.70M |
| Gross Profit | 583.87M | 519.10M | 485.33M | 401.18M | 432.37M | 394.77M | 326.25M | 265.03M | 235.78M | 225.22M | 194.37M | 181.99M | 165.47M | 128.50M | 108.80M | 93.27M | 79.79M | 73.08M | 69.09M | 67.49M | 60.72M | 48.52M | 38.10M | 34.94M | 33.70M | 28.80M | 25.50M | 23.60M | 19.30M | 15.90M | 13.10M | 10.80M | 6.70M | 2.40M | -300.00K |
| Gross Profit Ratio | 46.44% | 45.10% | 45.16% | 41.62% | 43.46% | 44.72% | 44.82% | 43.89% | 43.49% | 44.19% | 43.28% | 46.16% | 46.03% | 43.30% | 42.26% | 41.06% | 38.40% | 38.33% | 41.48% | 44.58% | 44.67% | 41.74% | 36.62% | 38.21% | 43.21% | 42.11% | 42.08% | 46.73% | 45.31% | 47.75% | 51.57% | 58.70% | 63.81% | 54.55% | -21.43% |
| Research & Development | 82.73M | 75.51M | 71.25M | 57.54M | 65.62M | 59.53M | 51.40M | 45.23M | 40.81M | 36.63M | 33.89M | 27.80M | 21.94M | 15.34M | 11.17M | 9.16M | 8.69M | 8.58M | 6.99M | 5.08M | 4.63M | 4.01M | 4.12M | 3.86M | 3.60M | 3.20M | 4.40M | 2.50M | 2.30M | 2.10M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 373.68M | 342.53M | 335.69M | 297.72M | 327.27M | 276.02M | 229.13M | 184.40M | 156.35M | 147.89M | 128.64M | 122.11M | 104.50M | 87.62M | 64.79M | 53.13M | 48.13M | 45.49M | 38.58M | 35.07M | 30.47M | 27.73M | 24.04M | 23.30M | 20.40M | 17.50M | 15.70M | 14.30M | 12.80M | 10.20M | 9.10M | 8.00M | 4.70M | 2.10M | 0.00 |
| Other Expenses | 3.52M | 966.00K | -2.51M | -2.28M | -537.00K | 63.00K | -872.00K | -773.00K | -386.00K | 18.00K | -216.00K | -1.65M | 5.84M | 8.34M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.32M | 3.60M | 2.80M | 2.70M | 2.40M | 1.70M | 1.60M | 1.40M | 1.10M | 500.00K | 200.00K | 100.00K |
| Operating Expenses | 459.93M | 418.04M | 406.94M | 355.26M | 392.89M | 335.55M | 280.54M | 229.63M | 197.16M | 184.53M | 162.53M | 149.90M | 126.44M | 102.95M | 75.96M | 62.29M | 56.82M | 54.07M | 45.57M | 40.15M | 35.09M | 31.74M | 28.16M | 31.48M | 27.60M | 23.50M | 22.80M | 19.20M | 16.80M | 13.90M | 10.50M | 9.10M | 5.20M | 2.30M | 100.00K |
| Cost & Expenses | 1.13B | 1.05B | 996.36M | 917.96M | 955.38M | 823.53M | 682.14M | 568.44M | 503.53M | 468.99M | 417.21M | 362.20M | 320.42M | 271.21M | 224.62M | 196.16M | 184.80M | 171.66M | 143.06M | 124.06M | 110.32M | 99.45M | 94.10M | 87.99M | 71.90M | 63.10M | 57.90M | 46.10M | 40.10M | 31.30M | 22.80M | 16.70M | 9.00M | 4.30M | 1.80M |
| Interest Income | 2.46M | 439.00K | 769.00K | 604.00K | 0.00 | 1.20M | 381.00K | 81.00K | 272.00K | 217.00K | 255.00K | 226.00K | 129.00K | 34.00K | 178.00K | 781.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 15.51M | 6.34M | 5.26M | 9.99M | 12.41M | 10.36M | 7.74M | 8.80M | 6.23M | 8.83M | 8.04M | 604.00K | 789.00K | 596.00K | 28.00K | 17.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 101.29M | 92.20M | 95.78M | 106.82M | 104.36M | 69.55M | 53.58M | 43.76M | 37.43M | 35.93M | 32.54M | 22.53M | 19.19M | 14.86M | 12.27M | 10.24M | 9.31M | 8.10M | 5.64M | 4.49M | 4.23M | 4.38M | 4.56M | 4.32M | 3.60M | 2.80M | 2.70M | 2.40M | 1.70M | 1.60M | 1.40M | 1.10M | 500.00K | 200.00K | 100.00K |
| EBITDA | 231.44M | 181.15M | 153.45M | 102.71M | 121.00M | 129.43M | 97.29M | 78.66M | 74.85M | 76.33M | 60.43M | 50.76M | 52.93M | 32.24M | 45.39M | 42.10M | 32.41M | 19.01M | 23.52M | 27.34M | 30.37M | 21.16M | 14.50M | 7.78M | 9.70M | 8.10M | 5.40M | 6.80M | 4.20M | 3.60M | 4.00M | 2.80M | 2.00M | 300.00K | -300.00K |
| EBITDA Ratio | 18.41% | 16.91% | 16.04% | 4.59% | 3.88% | 6.85% | 6.21% | 5.75% | 7.10% | 8.03% | 7.10% | 7.78% | 10.89% | 8.62% | 12.83% | 18.11% | 15.52% | 14.25% | 17.56% | 20.95% | 21.21% | 18.22% | 13.19% | 8.95% | 12.44% | 11.99% | 8.91% | 13.47% | 9.86% | 10.51% | 15.35% | 15.22% | 18.10% | 4.55% | -21.43% |
| Operating Income | 123.94M | 87.56M | 60.92M | -62.58M | -65.71M | 58.62M | 33.07M | 34.88M | 37.54M | 40.17M | 27.84M | 29.64M | 33.19M | 17.20M | 32.85M | 30.98M | 22.97M | 19.01M | 23.52M | 27.34M | 25.63M | 16.78M | 9.94M | 3.46M | 6.10M | 5.30M | 2.70M | 4.40M | 2.50M | 2.00M | 2.60M | 1.70M | 1.50M | 100.00K | -400.00K |
| Operating Income Ratio | 9.86% | 7.61% | 5.67% | -6.49% | -6.60% | 6.64% | 4.54% | 5.78% | 6.92% | 7.88% | 6.20% | 7.52% | 9.23% | 5.80% | 12.76% | 13.64% | 11.06% | 9.97% | 14.12% | 18.06% | 18.85% | 14.43% | 9.55% | 3.78% | 7.82% | 7.75% | 4.46% | 8.71% | 5.87% | 6.01% | 10.24% | 9.24% | 14.29% | 2.27% | -28.57% |
| Total Other Income/Expenses | -11.86M | -19.44M | -7.00M | -11.67M | -13.24M | -9.10M | 2.81M | -9.49M | -6.34M | -8.59M | -8.01M | -2.02M | -315.00K | -416.00K | 247.00K | 861.00K | 429.00K | 174.00K | 379.00K | 666.00K | 885.00K | -13.00K | -151.23K | -2.69M | -1.40M | -1.10M | -1.00M | -900.00K | -600.00K | 100.00K | 0.00 | 0.00 | 200.00K | 0.00 | 400.00K |
| Income Before Tax | 112.09M | 82.63M | 53.92M | -13.23M | 2.19M | 49.52M | 35.88M | 25.39M | 31.20M | 31.57M | 19.84M | 27.62M | 32.88M | 16.79M | 33.09M | 31.85M | 23.40M | 19.18M | 23.90M | 28.01M | 27.02M | 16.76M | 9.79M | 773.85K | 4.70M | 4.20M | 1.70M | 3.50M | 1.90M | 2.10M | 2.60M | 1.70M | 1.70M | 100.00K | -400.00K |
| Income Before Tax Ratio | 8.91% | 7.18% | 5.02% | -1.37% | 0.22% | 5.61% | 4.93% | 4.20% | 5.75% | 6.19% | 4.42% | 7.00% | 9.15% | 5.66% | 12.85% | 14.02% | 11.26% | 10.06% | 14.35% | 18.50% | 19.88% | 14.42% | 9.41% | 0.85% | 6.03% | 6.14% | 2.81% | 6.93% | 4.46% | 6.31% | 10.24% | 9.24% | 16.19% | 2.27% | -28.57% |
| Income Tax Expense | 17.68M | 8.11M | 5.46M | -3.39M | -3.26M | 7.50M | 8.36M | 5.27M | 7.40M | 8.60M | 3.27M | 7.91M | 9.83M | 4.33M | 10.56M | 11.12M | 7.81M | 6.88M | 8.12M | 10.07M | 9.73M | 5.45M | 3.05M | -52.71K | 1.50M | 1.70M | 900.00K | 1.30M | 700.00K | 800.00K | 800.00K | 500.00K | 400.00K | -100.00K | 400.00K |
| Net Income | 94.41M | 74.52M | 48.45M | -9.84M | 5.45M | 42.02M | 27.52M | 20.12M | 23.80M | 22.97M | 16.57M | 19.71M | 23.04M | 12.46M | 22.53M | 20.73M | 15.59M | 12.30M | 15.78M | 17.93M | 17.30M | 11.31M | 6.74M | 826.56K | 3.20M | 2.50M | 800.00K | 2.20M | 1.20M | 1.30M | 1.80M | 1.20M | 1.30M | 100.00K | -400.00K |
| Net Income Ratio | 7.51% | 6.47% | 4.51% | -1.02% | 0.55% | 4.76% | 3.78% | 3.33% | 4.39% | 4.51% | 3.69% | 5.00% | 6.41% | 4.20% | 8.75% | 9.13% | 7.50% | 6.45% | 9.47% | 11.84% | 12.72% | 9.73% | 6.47% | 0.90% | 4.10% | 3.65% | 1.32% | 4.36% | 2.82% | 3.90% | 7.09% | 6.52% | 12.38% | 2.27% | -28.57% |
| EPS | 1.64 | 1.31 | 0.86 | -0.18 | 0.10 | 0.80 | 0.56 | 0.45 | 0.54 | 0.53 | 0.39 | 0.47 | 0.59 | 0.35 | 0.64 | 0.60 | 0.46 | 0.36 | 0.47 | 0.54 | 0.53 | 0.37 | 0.24 | 0.03 | 0.12 | 0.10 | 0.03 | 0.09 | 0.05 | 0.05 | 0.08 | 0.05 | 0.06 | 0.01 | -0.03 |
| EPS Diluted | 1.62 | 1.29 | 0.84 | -0.18 | 0.10 | 0.78 | 0.55 | 0.45 | 0.53 | 0.53 | 0.39 | 0.46 | 0.58 | 0.34 | 0.63 | 0.58 | 0.44 | 0.35 | 0.46 | 0.52 | 0.51 | 0.34 | 0.23 | 0.03 | 0.12 | 0.10 | 0.03 | 0.09 | 0.05 | 0.05 | 0.08 | 0.05 | 0.06 | 0.01 | -0.03 |
| Weighted Avg Shares Out | 57.59M | 56.81M | 56.15M | 55.43M | 55.08M | 52.27M | 48.81M | 44.41M | 44.04M | 43.14M | 42.61M | 42.18M | 39.09M | 35.29M | 35.01M | 34.71M | 34.28M | 34.17M | 33.56M | 32.88M | 31.56M | 30.11M | 28.17M | 26.84M | 26.18M | 25.76M | 25.25M | 24.48M | 23.15M | 23.76M | 22.32M | 21.93M | 20.52M | 11.57M | 13.89M |
| Weighted Avg Shares Out (Dil) | 58.36M | 57.67M | 57.36M | 55.43M | 56.24M | 53.93M | 50.10M | 44.86M | 44.51M | 43.41M | 42.88M | 42.61M | 39.73M | 35.98M | 35.76M | 35.69M | 35.26M | 35.31M | 34.81M | 34.61M | 33.79M | 32.80M | 29.84M | 27.29M | 26.27M | 26.00M | 25.25M | 24.59M | 23.15M | 23.76M | 22.32M | 21.93M | 20.52M | 11.57M | 13.89M |
Merit Medical Systems, Inc. (MMSI) Q4 2023 Earnings Call Transcript
Merit Medical Systems, Inc. (MMSI) Q4 2023 Earnings Call Transcript
Compared to Estimates, Merit Medical (MMSI) Q4 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Merit Medical (MMSI) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street...
Merit Medical (MMSI) Q4 Earnings and Revenues Surpass Estimates
Merit Medical (MMSI) came out with quarterly earnings of $0.81 per share, beating the Zacks Consensus Estimate of $0.77 per share. This compares to earnings of $0.79 per share a year ago.
Merit Medical Introduces “Continued Growth Initiatives” Program and Financial Targets for Three-Year Period Ending December 31, 2026
SOUTH JORDAN, Utah, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today introduced its Continued Growth Initiatives Program and related financial targets for the three-year period ending...
Merit Medical Reports Results For Fourth Quarter and Year Ended December 31, 2023 - Issues Fiscal Year 2024 Guidance
* Constant currency revenue; constant currency revenue, organic; non-GAAP EPS; non-GAAP net income; non-GAAP operating income and margin; non-GAAP gross profit and margin; and free cash flow are non-GAAP financial measures. A reconciliation of these financial measures to their most directly...
Stay Ahead of the Game With Merit Medical (MMSI) Q4 Earnings: Wall Street's Insights on Key Metrics
Besides Wall Street's top -and-bottom-line estimates for Merit Medical (MMSI), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2023.
Merit Medical (MMSI) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Merit Medical (MMSI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Merit Medical's (MMSI) SCOUT Guidance System Gets FDA Nod
Merit Medical's (MMSI) SCOUT MD Surgical Guidance System receives FDA clearance, which aims to boost the treatment of breast cancer by increasing accuracy to target tumor sites.
Merit Medical Receives FDA 510(k) Clearance for SCOUT® MD™ Surgical Guidance System
New guidance system marks significant advancement in breast cancer care, targeting tumor location in multiple dimensions for precise excision and successful surgeries New guidance system marks significant advancement in breast cancer care, targeting tumor location in multiple dimensions for precise...
MMSI vs. ALGN: Which Stock Is the Better Value Option?
Investors interested in Medical - Dental Supplies stocks are likely familiar with Merit Medical (MMSI) and Align Technology (ALGN). But which of these two stocks presents investors with the better value opportunity right now?
Source: https://incomestatements.info
Category: Stock Reports